Oct 10, 2018
Invariant Natural Killer T Cells Might Be The Next Step in Cancer Therapy
Posted by Nicola Bagalà in categories: biotech/medical, engineering, neuroscience
Invariant natural killer T cells might lead to cheaper and more effective immunotherapy.
Researchers at the Imperial College London have discovered that specifically employing invariant natural killer T cells, rather than generic T cells, in cancer immunotherapies based on chimeric antigen receptors might lead to significantly more effective, cheaper, and more easily mass-produced treatments [1].
Abstract
Continue reading “Invariant Natural Killer T Cells Might Be The Next Step in Cancer Therapy” »